Merck Hdac Research, LLC
Records under this name other than the patents Merck Hdac Research, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Showing 1 to 10 of 10 · Back to Merck Hdac Research, LLC
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,456,219 | Polymorphs of Suberoylanilide Hydroxamic Acid Formerly held Term ended Term ended Jul 15, 2025 · High confidence | Term ended | Term ended Jul 15, 2025 | High confidence |
| US 7,399,787 | Methods of Treating Cancer with Hdac Inhibitors Term ended Term ended Feb 9, 2025 · High confidence | Term ended | Term ended Feb 9, 2025 | High confidence |
| US 7,847,122 | Polymorphs of Suberoylanilide Hydroxamic Acid Term ended Term ended May 15, 2024 · High confidence | Term ended | Term ended May 15, 2024 | High confidence |
| US 7,851,509 | Polymorphs of Suberoylanilide Hydroxamic Acid Term ended Term ended Feb 21, 2024 · High confidence | Term ended | Term ended Feb 21, 2024 | High confidence |
| US 7,148,257 | Methods of Treating Mesothelioma with Suberoylanilide Hydroxamic Acid Term ended Term ended Mar 4, 2023 · High confidence | Term ended | Term ended Mar 4, 2023 | High confidence |
| US 7,375,137 | Methods of Treating Cancer with Hdac Inhibitors Term ended Term ended Mar 4, 2023 · High confidence | Term ended | Term ended Mar 4, 2023 | High confidence |
| US 7,652,069 | Polymorphs of Suberoylanilide Hydroxamic Acid Term ended Term ended Mar 4, 2023 · High confidence | Term ended | Term ended Mar 4, 2023 | High confidence |
| US 8,067,472 | Methods of treating Hodgkin's and non-Hodgkin's lymphoma Term ended Ended no later than Mar 4, 2023 · Medium confidence | Term ended | Ended no later than Mar 4, 2023 | Medium confidence |
| US 8,101,663 | Polymorphs of Suberoylanilide Hydroxamic Acid Term ended Ended no later than Mar 4, 2023 · Medium confidence | Term ended | Ended no later than Mar 4, 2023 | Medium confidence |
| US 8,227,636 | Histone Deacetylase Inhibitor Prodrugs Lapsed on the fee record Ended Jul 24, 2020 · High confidence | Lapsed on the fee record | Ended Jul 24, 2020 | High confidence |